What drove the intraday move in 1093.HK stock today?

Heavy trading and sector rotation into healthcare drove the intraday move. Volume was **218,580,273** versus an average of **119,109,058**, suggesting strong buyer interest rather than a fundamental news release.

What is Meyka AI’s short-term forecast for 1093.HK stock?

Meyka AI's forecast model projects a monthly price of **HK$10.94**, implying about **+10.62%** from the current **HK$9.89**. Forecasts are model-based and not guarantees.

What valuation metrics should investors watch for 1093.HK stock?

Key metrics include trailing P/E **26.03**, price-to-book **3.02**, dividend yield **2.43%**, and free cash flow yield **1.48%**. Compare these with peers in the Hong Kong healthcare sector before acting.

When is CSPC’s next earnings report and why does it matter?

Earnings are scheduled for 25 March 2026. The report matters because recent growth rates have slowed and results will affect guidance, valuation, and intraday liquidity ahead of any revisions.

HK Stocks

1093.HK CSPC Pharma (HKSE) up 8.09% to HK$9.89 on 04 Feb 2026: heavy volume signals follow-through

ByDanny Kontos February 4, 2026February 4, 2026

1093.HK stock jumped 8.09% to HK$9.89 intraday on 04 Feb 2026 on the HKSE, driven by a large trade volume of 218,580,273 shares. The move lifted price well above the 50-day average of HK$8.69 and 200-day average of HK$8.55, marking a clear short-term breakout in Hong Kong healthcare. Traders are watching whether the surge continues into the close and ahead of an earnings date set for 25 March 2026. We review volume, fundamentals, technicals, and Meyka AI model forecasts to set near-term price targets and risks for CSPC Pharmaceutical Group Limited (1093.HK)